THE 2026 COMMERCIAL REALITY

Innovation is Table Stakes.

Market Dominance is Architected.

Stop marketing to clinicians. Start solving for the actuary. I build the commercial engines that translate clinical potential into audit-survivable revenue.

Cinematic, wide-angle shot of a high-tech _War Room_ command center. A massive glass wall

National Ecosystem Reach

Architecting commercial pathways for clients operating across the Top 10 National Payers, Providers, and Biopharma companies. We align innovation with the economic requirements of portfolios covering over 100M+ total lives.

High-Growth Deployment

Designed the go-to-market architecture to activate 1M+ eligible lives for emerging medical technology, converting clinical potential into a scalable commercial footprint and high-value payer contracts.

Multi-Channel Architecture

Navigating the intersection of early-stage innovation and enterprise-scale health systems. We design the contracting logic and commercial pathways that allow startups and growth-stage companies to successfully integrate with National Payers, Providers, and the Top 10 Global Biopharma ecosystem.

COMMERCIAL OPERATING ARCHITECTURE

We move beyond traditional consulting to build the structural foundations required for enterprise scale. We design the economic logic, institutional pathways, and leadership rhythms that translate clinical potential into high-value revenue and market dominance.

Cinematic, low-key photograph of a professional hand marking a document with a stylus. The

PAYER & ECONOMIC ARCHITECTURE

Stop selling clinical hope. We design the audit-survivable economic models and contracting logic required to secure high-value payer contracts and sustainable reimbursement.

Abstract architectural shot of a modern glass medical research facility or hospital atrium

ENTERPRISE ADOPTION PATHWAYS

We bridge the gap between validated outcomes and institutional adoption, architecting the clear commercial pathways required to scale within the Top 10 National Provider ecosystems.

A candid, close-up shot of two professionals in a dark-themed, modern office leaning over

EMBEDDED COMMERCIAL LEADERSHIP

This is not advisory. We embed as your fractional commercialization function, operating the revenue engine and leading the charge from initial pilot to national enterprise scale.

PARTNERSHIP APPROACH

We move beyond advisory to deploy the structural foundations required for enterprise scale. Axis aligns innovation with the economic requirements of the Top 10 National Payer and Provider ecosystems.

A low-key, professional architectural photograph set in a vast, dark stone hall. Two refin

Venture-Backed Founders

We partner with CEOs and PE leadership moving from clinical proof to market dominance. We bridge the gap between validated outcomes and institutional adoption.

A close-up, complex photograph of intertwined, glowing white and slate-grey structural gla

Commercial Infrastructure

We design the contracting logic and economic pathways required for scale. We translate clinical data into the audit-survivable revenue models payers demand.

A cinematic photograph capturing a top-d

Deployment Models

From 90-day Architecture Sprints that de-risk your market pathway to 6–18 month Embedded Leadership that operates your revenue engine.

The Axis Perspective

The Problem

Most healthtech innovations possess strong science but fail to translate clinical proof into the economic logic required for institutional adoption. Outcomes alone don’t drive contracts. Audit-survivable revenue models do.

The Perspective

Tom Riley founded Axis to bridge the gap between clinical validation and commercial reality. Drawing on a career managing $4B+ portfolios and navigating the Payer-Provider-Biopharma triangle—with leadership tenures at Genentech, Kaiser Permanente, Deloitte, and CVS Health/Aetna—Tom architected Axis to solve for the actuary as much as the clinician.

The Reality

This is not advisory. We design and operate the commercial engines that navigate IRA impacts, optimize 340B dynamics, and activate multi-channel distribution. We don't just find a path; we build the infrastructure for market dominance.

The New Rules of Biopharma Commercialization: Where the Money Is Moving, What the Data Demands, and Why 2026 Is the Year That Changes Everything

By Axis Growth Partners The biopharma commercialization playbook that worked in 2015 — and even 2020 — is functionally obsolete. A confluence of legislative pressure, shifting payer power, PE and VC platform consolidation, and an explosion of patient-centric data intelligence has fundamentally rewritten how drugs reach patients and generate revenue. For anyone operating at the intersection of biotech, private equity, and commercial strategy, understanding these tectonic shift

MA Arbitrage Is Collapsing

CMS Made It Official. Medicare is undergoing a structural shift most healthcare operators and healthtech companies are misreading. This isn’t a policy tweak.It ’s the collapse of the economic arbitrage that made Medicare Advantage dominant for a decade. And CMS is now absorbing that power directly. The Real Shift: CMS Is Repricing Risk Without Intermediaries The ACCESS model is being described as “just another pilot.” That framing is wrong. ACCESS does three things MA plans h

The ACCESS Era: How 2026 Rewrites Growth, Valuation & Contracting in U.S. Health Care

A CEO Briefing by Axis Growth Partners — Commercialization Architecture™ ACCESS Isn’t a Policy Update. It’s the 2026 Market Separation Event. ACCESS is not a single CMS program. It is the combined economic force of: 2024–2026 mental-health parity (MHPAEA) enforcement , 2025 CMS Interoperability & Prior Authorization Final Rule , 2026–2027 Medicare Advantage (MA) network adequacy modernization , and Explosive GLP-1 drug cost pressure now reshaping benefits. Together, these cha

Move Beyond Advisory. Architect Your Market Dominance.

Axis Growth Partners moves beyond traditional advisory to deploy the structural foundations required for enterprise scale. We identify the specific points of friction within your growth model—from misaligned payer incentives to institutional adoption barriers—and architect the contracting logic and commercial rhythms required to overcome them.

If you are clarifying your commercialization model or preparing to scale adoption across National Payer, Provider, and Employer channels, let’s align on a deployment path. From 90-day Architecture Sprints to embedded commercial leadership, we build the infrastructure for market dominance.

info@axisgrowthpartners.co